{"id":"bleomycin-etoposide-and-cisplatin","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Ototoxicity"},{"rate":null,"effect":"Pulmonary toxicity (bleomycin-related)"},{"rate":null,"effect":"Peripheral neuropathy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bleomycin causes DNA strand breaks and prevents DNA repair; etoposide inhibits topoisomerase II to prevent DNA unwinding and replication; cisplatin is a platinum-based alkylating agent that cross-links DNA. Together, these agents work synergistically to induce apoptosis in rapidly dividing cancer cells.","oneSentence":"This combination chemotherapy regimen uses three agents that damage DNA and inhibit cell division to kill cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:31.070Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Germ cell tumors (testicular cancer)"},{"name":"Lymphomas"},{"name":"Small cell lung cancer"}]},"trialDetails":[{"nctId":"NCT03067181","phase":"PHASE3","title":"Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-05-25","conditions":"Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor","enrollment":1780},{"nctId":"NCT02341989","phase":"PHASE3","title":"Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2015-04-08","conditions":"Testicular Neoplasms, Seminoma","enrollment":348},{"nctId":"NCT06144736","phase":"PHASE2","title":"PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-08-28","conditions":"Seminoma","enrollment":60},{"nctId":"NCT01873326","phase":"PHASE2","title":"Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-06","conditions":"Germ Cell Tumors","enrollment":92},{"nctId":"NCT02582697","phase":"PHASE3","title":"Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2014-02","conditions":"Germ Cell Tumor","enrollment":500},{"nctId":"NCT05705687","phase":"NA","title":"Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-05-05","conditions":"Non-Seminomatous Germ Cell Tumor","enrollment":150},{"nctId":"NCT00104676","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2003-11-26","conditions":"Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor","enrollment":263},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT01858922","phase":"PHASE2","title":"Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2012-12-19","conditions":"Hodgkin Disease","enrollment":40},{"nctId":"NCT02429700","phase":"PHASE3","title":"TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors","status":"RECRUITING","sponsor":"Beihua Kong","startDate":"2015-04","conditions":"Ovarian Sex Cord Stromal Tumor, Ovarian Neoplasms, Ovarian Cancer","enrollment":132},{"nctId":"NCT02429687","phase":"PHASE3","title":"TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors","status":"RECRUITING","sponsor":"Beihua Kong","startDate":"2015-04","conditions":"Ovarian Germ Cell Cancer, Ovarian Neoplasms, Ovarian Cancer","enrollment":129},{"nctId":"NCT01042522","phase":"PHASE2","title":"Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors","status":"UNKNOWN","sponsor":"GOG Foundation","startDate":"2010-02-08","conditions":"Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor","enrollment":63},{"nctId":"NCT00053352","phase":"PHASE3","title":"Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-11-03","conditions":"Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor","enrollment":302},{"nctId":"NCT00577993","phase":"PHASE3","title":"Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1998-03-16","conditions":"Lymphoma","enrollment":210},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT00002835","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1995-10-30","conditions":"Lymphoma","enrollment":116},{"nctId":"NCT00002565","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1994-05-25","conditions":"Lymphoma","enrollment":61},{"nctId":"NCT00025259","phase":"PHASE3","title":"Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2002-09","conditions":"Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma, Childhood Mixed Cellularity Classical Hodgkin Lymphoma, Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma","enrollment":1734},{"nctId":"NCT00920153","phase":"PHASE3","title":"Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma","status":"TERMINATED","sponsor":"French Innovative Leukemia Organisation","startDate":"2008-05","conditions":"Lymphoma","enrollment":442},{"nctId":"NCT00429754","phase":"PHASE4","title":"Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)","status":"WITHDRAWN","sponsor":"Radboud University Medical Center","startDate":"","conditions":"Nausea, Vomiting","enrollment":""},{"nctId":"NCT02161692","phase":"PHASE2","title":"Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors","status":"COMPLETED","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"1996-12","conditions":"Testicular Neoplasms, Germ Cell Tumors","enrollment":""},{"nctId":"NCT00066482","phase":"NA","title":"Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-07","conditions":"Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor","enrollment":19},{"nctId":"NCT00274950","phase":"PHASE3","title":"Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2005-05","conditions":"Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer","enrollment":105},{"nctId":"NCT00301782","phase":"PHASE2","title":"Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2005-06","conditions":"Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor","enrollment":88},{"nctId":"NCT00324298","phase":"PHASE3","title":"Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2003-07","conditions":"Drug/Agent Toxicity by Tissue/Organ, Testicular Germ Cell Tumor","enrollment":210},{"nctId":"NCT00025064","phase":"PHASE2","title":"Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2000-01","conditions":"Lymphoma","enrollment":260},{"nctId":"NCT00453232","phase":"PHASE2","title":"Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2004-08","conditions":"Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor","enrollment":20},{"nctId":"NCT00003811","phase":"PHASE2","title":"Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-04","conditions":"Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor","enrollment":27},{"nctId":"NCT00002596","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1994-09","conditions":"Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor","enrollment":270},{"nctId":"NCT00003941","phase":"PHASE3","title":"Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1999-04","conditions":"Mediastinal Cancer, Metastatic Cancer, Testicular Germ Cell Tumor","enrollment":222},{"nctId":"NCT00002524","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1993-06","conditions":"Lymphoma","enrollment":46},{"nctId":"NCT00003643","phase":"PHASE2, PHASE3","title":"Combination Chemotherapy in Treating Men With Germ Cell Cancer","status":"UNKNOWN","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1998-10","conditions":"Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor","enrollment":498},{"nctId":"NCT00970385","phase":"PHASE3","title":"Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"1995-01","conditions":"Peripheral T Cell Lymphoma","enrollment":95}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["BEP"],"phase":"phase_3","status":"active","brandName":"Bleomycin Etoposide and Cisplatin","genericName":"Bleomycin Etoposide and Cisplatin","companyName":"St. Olavs Hospital","companyId":"st-olavs-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination chemotherapy regimen uses three agents that damage DNA and inhibit cell division to kill cancer cells. Used for Germ cell tumors (testicular cancer), Lymphomas, Small cell lung cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}